Clusterin as a blood biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease

With increasing global life expectancy, Alzheimer's disease will become an increasingly prevalent health problem. The development of biomarkers that predict risk for both Alzheimer's disease and mild cognitive impairment will be useful for early diagnosis of dementia. To date, no surrogate...

Full description

Saved in:
Bibliographic Details
Main Authors: Panachamnong,N., Methapatara,P., Sungkarat,S., Taneyhill,K., Intasai,N.
Format: Article
Published: Chiang Mai University 2015
Subjects:
Online Access:http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84908378905&origin=inward
http://cmuir.cmu.ac.th/handle/6653943832/38127
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University